Unisound AI Technology Co., Ltd. disclosed that key insiders increased their stakes in the company’s H-shares between 6 July and 16 July 2026.

• Controlling shareholder, executive director and CEO Dr. Huang Wei bought 56,000 H-shares on the open market for HK$3.98 million. His direct holding now stands at 56,000 H-shares, while his deemed interest through Yunsi Shangyi and Yunchuang Hudong totals 19,349,872 shares. Combined, Dr. Huang holds 19,405,872 shares, representing 25.99 % of Unisound AI’s 74,675,593 issued shares.

• Executive director Dr. Liu Shengping acquired 15,140 H-shares for HK$1.13 million, bringing his direct ownership to 0.02 % of the company’s total share capital.

• Acting in concert, Dr. Huang Wei, Dr. Liang Jia’en and Dr. Kang Heng now control 23,601,661 shares—31.61 % of all shares outstanding—comprising 16,481,964 Domestic Unlisted Shares and 7,119,697 H-shares.

The company confirmed that no controlling shareholder has reduced holdings since listing. Dr. Huang Wei intends to further increase his H-share position subject to market conditions and regulatory limits, ensuring no mandatory general offer is triggered under Hong Kong’s Takeovers Code.

Shareholders and prospective investors are advised to exercise caution when trading the company’s securities.